Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-03-17

Clinical Trial Update: Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis [NA]

View source ↗

Summary

Clinical trial update on cross-validating a predictive model of response to anti-TNF therapy in rheumatoid arthritis using oxylipin response; status is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Rheumatoid Arthritis | NA | Status: NOT_YET_RECRUITING